Author

H. Karner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

H. Goodarzi· 2 shared K. Garcia· 2 shared A. Arab· 1 shared A. Keshavarzi Arshadi· 1 shared A. Navickas· 1 shared B. J. Woo· 1 shared B. Wang· 1 shared F. Y. Feng· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Goodarzi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer

B. J. Woo, R. Moussavi-Baygi, H. Karner, M. Karimzadeh, K. Garcia, T. Joshi, K. Yin, A. Navickas, L. A. Gilbert, B. Wang, H. Asgharian, F. Y. Feng, H. Goodarzi

This study identifies non-coding regulatory regions driving metastatic prostate cancer using an integrative computational and experimental approach.

bioRxiv · Apr 14, 2023Cancer Biology

Functional microRNA-Targeting Drug Discovery by Graph-Based Deep Learning

A. Keshavarzi Arshadi, M. Salem, H. Karner, K. Garcia, A. Arab, J. S. Yuan, H. Goodarzi

This study develops RiboStrike, a deep learning framework to identify small molecules targeting microRNAs, demonstrating its effectiveness in finding anti-miR-21 compounds with cancer therapeutic potential.

bioRxiv · Jan 13, 2023Cancer Biology